Label (71610 813 26)
Cilostazol Tablet
Product Images NDC 71610-813
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 71610-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena (Aphena)
Figure1.jpg (Figure1)
Figure2.jpg (Figure2)
This text appears to be discussing the percent mean improvement in maximal walking distance with different treatments. The treatments administered include Placebo, Cilostazol 50 mg b.i.d, and Cilostazol 100 mg b.i.d. The improvement in walking distance is evaluated over 12 weeks.*
Structure.jpg (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
